Rubén Lima Flores

Iquiqueño - 👨‍👩‍👦‍👦 - Cirujano Oncólogo Digestivo y Sarcomas🩸🔪😷 Gamer 👾🎮

[RedCiruAndes @CiruAndes2]

The 11 steps to perform a laparoscopic splenectomy ⤵️💡⚡️🤖💥! #SoMe4Surgery @PipeCabreraV @juliomayol @pferrada1 @SWexner

[ASCO @ASCO]

Don't miss oncology's premier international scientific gathering of GI cancer professionals. Register for #GI24!

[Rubén Lima Flores @GunnerIQQ]

@AyudaMovistarCL llevo dos dias sin internet ni tv, en la region de Coquimbo!!!

[Rubén Lima Flores @GunnerIQQ]

¿Recuerdas cuando te uniste a Twitter? ¡Yo sí! #MiAniversarioDeTwitter

🤨🧐

[Rubén Lima Flores @GunnerIQQ]

⭐️⭐️⭐️⭐️⭐️

[Arndt Vogel @ArndtVogel]

😇Now fully published:
🇪🇺Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
@Annals_Oncology
👇https://t.co/vQT1xsLc2T
@myESMO @EASLedu #livertwitter @CcaEns

[Rubén Lima Flores @GunnerIQQ]

Hoy 4 de Febrero, día mundial contra el cáncer. Juntos podemos sacar la tarea adelante. #cancer #cancerday en Santiago Metropolitan Region https://t.co/9Ckz4luEy8

[Rubén Lima Flores @GunnerIQQ]

Upaaaaaaaa!!!

[The Winery Dogs @TheWineryDogs]

Seems like The Dogs are going to a land of good carménères... Se viene weón! 🇨🇱

[Rubén Lima Flores @GunnerIQQ]

#espectacular #coloncancer #oncology

[Jenny Seligmann @JenSeligmann]

🥁🥁🥁Tweetorial
FOxTROT, the 1st ph 3 RCT of neoadjuvant chemo (NAC) in locally advanced colon cancer
We report that NAC is
✅deliverable and safe
✅led to statistically significant reduction in cancer recurrence than upfront surgery
A 🧵 (1/14)
#crcsm
https://t.co/y1hU6qWdXF

[Jenny Seligmann @JenSeligmann]

🥁🥁🥁Tweetorial
FOxTROT, the 1st ph 3 RCT of neoadjuvant chemo (NAC) in locally advanced colon cancer
We report that NAC is
✅deliverable and safe
✅led to statistically significant reduction in cancer recurrence than upfront surgery
A 🧵 (1/14)
#crcsm
https://t.co/y1hU6qWdXF

[Alvaro Arjona @alarjosan]

Próximo 24 de enero discutiremos sobre los avances en el tratamiento de la carcinomatosis peritoneal de origen colorectal, organizado por @GrupoTTD presentaremos resultados de HIPECT4 trial. @HUReinaSofia @IMIBIC @myESMO @_SEOM @indepso @ESSOnews @operarelcancer

[Alvaro Arjona @alarjosan]

After HIPECT4 results decreasing the risk of peritoneal relapse in cT4 colon cancer, we use this approach routinely, and you? Publication is coming ! https://t.co/SpwGyh681Y @GECOPeritoneal @operarelcancer @myESMO @ESSOnews @_SEOM @aecirujanos @indepso @ISSPP1 @PSOGI_EC

[Rubén Lima Flores @GunnerIQQ]

Simplemente el #rey . El mejor de todos los tiempos ⚽️1940-2022 en Iquique, Tierra De Campeones https://t.co/IOoUNl8bmk

[Rubén Lima Flores @GunnerIQQ]

#HIPEC

[Rubén Lima Flores @GunnerIQQ]

Notable @evelynmatthei , de frente como debe ser.

[Partido del Orden 🇨🇱 @partidodelorden]

Notable @evelynmatthei . En sus caras y sin anestesia.

[Partido del Orden 🇨🇱 @partidodelorden]

Notable @evelynmatthei . En sus caras y sin anestesia.

[Rubén Lima Flores @GunnerIQQ]

Tarjeta de presentación en La Serena, Chile https://t.co/YfKuCBCTq8

[Rubén Lima Flores @GunnerIQQ]

#surgicaloncology #cirugiaoncologica #cirugia #cirugiageneral @redsaludcchc en La Serena, Chile https://t.co/16X63Rncmf

[Syed A. Ahmad @SyedAAhmad5]

Just got these in the mail this morning. Thank you @timpawlik for the privilege of editing this book along with Shishir Maithel. It’s a great summary of trials relevant to surgical oncologist. Thanks also to all the authors. @UCincyMedicine @UCincySurg @cincysurgery

[Jean-Nicolas Vauthey MD @VautheyMD]

A high quality textbook #colorectalcancer & perfect holiday gift for surgeons and oncologists #oncsurgery 💫 My heartfelt thanks to all the experts who contributed 👏 @SSATNews @IHPBA @AHPBA @EAHPBA @SocSurgOnc @FightCRC @MDAndersonNews https://t.co/hHuJoWg11d

[Rubén Lima Flores @GunnerIQQ]

Nice!

[European Journal of Surgical Oncology @ejsotweets]

The Special Issue dedicated to Advanced Pelvic Malignancies is out! Massive kudos to @HelenMohan1 who edited the SI and put together a stellar team of world-renowned experts dedicated to this challenging field

Full issue 👉 https://t.co/8tBSwo3bGh

@ESSOnews @EYSAC1 @BASO_ACS